These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22791060)

  • 1. Effect of brow lifting using botulinum a toxin on upper eyelid height in patients with ptosis undergoing the frontal sling technique.
    Isik D; Tekin H; Karadag R; Bilgili SG; Atik B
    Ann Plast Surg; 2013 Feb; 70(2):175-9. PubMed ID: 22791060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence of Upper Blepharoptosis After Cosmetic Botulinum Toxin Type A.
    Steinsapir KD; Groth MJ; Boxrud CA
    Dermatol Surg; 2015 Jul; 41(7):833-40. PubMed ID: 26057409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of botulinum toxin in correcting frontalis-induced eyelid pseudo-retraction post ptosis surgery.
    Shome D; Jain V; Natarajan S
    Indian J Ophthalmol; 2007; 55(4):307-8. PubMed ID: 17595485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Management of upper eyelid retraction associated with dysthyroid orbitopathy during the acute inflammatory phase with botulinum toxin type A].
    Nava Castañeda A; Tovilla Canales JL; Garnica Hayashi L; Velasco Y Levy A
    J Fr Ophtalmol; 2017 Apr; 40(4):279-284. PubMed ID: 28336282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of botulinum toxin in correcting frontalis-induced eyelid pseudo-retraction post ptosis surgery.
    Dash SK
    Indian J Ophthalmol; 2008; 56(1):87-8. PubMed ID: 18158422
    [No Abstract]   [Full Text] [Related]  

  • 6. Open loop fascial sling for severe congenital blepharoptosis.
    Arajy ZY
    J Craniomaxillofac Surg; 2012 Feb; 40(2):129-33. PubMed ID: 21821427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Botulotoxin type A (lantox) for inducing temporal ptosis in neurosurgical patients].
    Tabashnikova TV; Serova NK; Shimanskiĭ VN; Grigor'eva NN
    Zh Vopr Neirokhir Im N N Burdenko; 2012; 76(4):43-8; discussion 48. PubMed ID: 23033592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Protective ptosis by botulinum A toxin injection in corneal affectations].
    Gusek-Schneider GC; Erbguth F
    Klin Monbl Augenheilkd; 1998 Jul; 213(1):15-22. PubMed ID: 9743934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of severe ptosis by suspension of the upper eyelid using the autogenic frontal muscle and fascia lata. Analysis of 34 interventions].
    Reny A; George JL
    J Fr Ophtalmol; 1983; 6(10):797-807. PubMed ID: 6672055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of postoperative eyelid height after frontalis suspension using autogenous fascia lata for pediatric congenital ptosis.
    Kim CY; Yoon JS; Bae JM; Lee SY
    Am J Ophthalmol; 2012 Feb; 153(2):334-342.e2. PubMed ID: 21982105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of levator excision followed by fascia lata brow suspension in patients with congenital and jaw-winking ptosis.
    Cates CA; Tyers AG
    Orbit; 2008; 27(2):83-9. PubMed ID: 18415867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The application of Dysport® - the possibilities of the side effect on the eyelids position (a clinical - histological study)].
    Krásný J; Sach J
    Cesk Slov Oftalmol; 2012 Nov; 68(5):216-20. PubMed ID: 23461374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frontalis Linkage Without Intraoperative Eyelid Elevation for the Management of Myopathic Ptosis.
    Diniz SB; Akaishi PM; Cruz AAV
    Ophthalmic Plast Reconstr Surg; 2020; 36(3):258-262. PubMed ID: 31809486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin-A-induced protective ptosis in the treatment of lagophthalmos associated with facial paralysis.
    Yücel OE; Artürk N
    Ophthalmic Plast Reconstr Surg; 2012; 28(4):256-60. PubMed ID: 22785583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paradoxical use of frontalis muscle and the possible role of botulinum a toxin in permanent motor relearning.
    Ben Simon GJ; Blaydon SM; Schwarcz RM; Nakra T; Goldberg RA; McCann JD
    Ophthalmology; 2005 May; 112(5):918-22. PubMed ID: 15878076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to avoid brow ptosis after forehead treatment with botulinum toxin.
    Redaelli A; Forte R
    J Cosmet Laser Ther; 2003 Dec; 5(3-4):220-2. PubMed ID: 14741838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of eyelid botulinum toxin injection on lacrimal drainage.
    Sahlin S; Chen E; Kaugesaar T; Almqvist H; Kjellberg K; Lennerstrand G
    Am J Ophthalmol; 2000 Apr; 129(4):481-6. PubMed ID: 10764857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re: "Botulinum toxin type A for dysthyroid upper eyelid retraction".
    Fay A
    Ophthalmic Plast Reconstr Surg; 2005 Jan; 21(1):81; author reply 81-2. PubMed ID: 15677964
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of apraclonidine eyedrops to treat ptosis after the administration of botulinum toxin to the upper face.
    Scheinfeld N
    Dermatol Online J; 2005 Mar; 11(1):9. PubMed ID: 15748550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and efficiency of a small-incision, minimal dissection procedure versus a traditional approach for correcting aponeurotic ptosis.
    Frueh BR; Musch DC; McDonald HM
    Ophthalmology; 2004 Dec; 111(12):2158-63. PubMed ID: 15582068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.